Lenacapavir Approved in Uganda for HIV Prevention
Uganda has approved lenacapavir for HIV prevention, a twice-yearly injectable PrEP. Clinical trials in Uganda and South Africa showed it stops over 99% of new HIV infections. The National Drug Authority (NDA)